A first-in-human phase I trial of PBI-05204 (oleandrin), an inhibitor of Akt, FGF-2, NF-Kb, and p 70S6K in advanced solid tumor patients - Bidyasar, S; Kurzrock, R; Falchook, G S; Naing, A; Wheler, J J; Durand, J; Yang, P; Johansen, M J; Newman, R A; Khan, R; Hong, D (J Clin Oncol, 2009)